The largest database of trusted experimental protocols

19 protocols using bapta am

1

Neutrophil Inhibition Prior to Yersinia Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
BAPTA-AM (Life Technologies) and EHT 1864 (Cayman Chemical Company) were reconstituted in dimethyl sulfoxide (DMSO) and added to the designated neutrophil wells for final concentrations of 50 μM (EHT 1864) and 25 μM (BAPTA-AM) after allowing the freshly isolated neutrophils to rest at 37°C for 30 min. After adding the inhibitors, neutrophils were incubated at 37°C for an additional 30 min prior to inoculation with Y. pestis.
+ Open protocol
+ Expand
2

Ferroptosis Inhibitors and Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Erastin (cat. no. E7781), ferrostatin‐1 (Fer‐1; cat. SML0583), and liproxstatin‐1 (Lpx‐1; cat. SML1414) were purchased from Sigma‐Aldrich (Saint Louis, MO, USA). (1S,3R)‐RSL3 (cat. HY‐100218A) was purchased from MedChem Express (Monmouth Junction, NJ, USA). EGTA‐AM (cat. 20401) and BAPTA‐AM (cat. 15551) were from Cayman Chemical (Ann Arbor, MI, USA). Antibodies against MNX1 (Hb9) were from Developmental Studies Hybridoma Band (cat. 81.5C10) (Iowa City, IA, USA), beta3‐tubulin was from Cell Signaling Technology (cat. 5568) (Danvers, MA, USA), and actin was from Santa Cruz Biotechnology (cat. no. sc‐1616‐R) (Dallas, TX, USA). Antibodies against choline acetyltransferase (ChAT) and GPx4 were from Abcam (cat. ab178859 and ab125066, respectively) (Cambridge, MA, USA). Secondary antibodies against mouse IgG and rabbit IgG were from LI‐COR Biotechnology (cat. 925‐68070 and 925‐68071) (Lincoln, NE, USA).
+ Open protocol
+ Expand
3

Leucine Stimulation in Cultured Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Almost confluent cultures in 6-well plates were washed once with leucine-free low glucose DMEM (US Biological), incubated in leucine-free DMEM for 3 hr, and stimulated with 52 μg/ml leucine for 10 min. For those cells treated with calmidazolium (CMDZ, Cayman Chemical) or BAPTA-AM (Cayman Chemical), compounds were added 1 hr prior to cell harvesting. Cells were processed for biochemical assays as described below.
+ Open protocol
+ Expand
4

Lipid Reconstitution and Protein Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
N-ethyl maleimide (NEM), dithiothreitol (DTT) and myriocin were from Sigma-Aldrich, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanol-amine (DOPE) and 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoethanolamine (NBD-PE) from Avanti Polar Lipids, and dithiobis(succinimidyl-propionate) (DSP), mouse monoclonal anti-HA agarose beads, C6-NBD-ceramide and N3-Alexa-Fluor647 from Thermo Fischer Scientific. Curcumin and thapsigargin were from Enzo Life Sciences, tamoxifen, fuminosin B1 and BAPTA-AM from Cayman, z-VAD-fmk from Merck Millipore, and L-arabinose from Carl Roth. Mouse monoclonal anti-V5 agarose beads were from Bethyl Laboratories and Ni-NTA agarose from Qiagen.
+ Open protocol
+ Expand
5

Elucidating IGF-II Signaling Pathways in Senescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
IGF-II signal transduction may occur through different pathways (Figure 5a). We determined which of these could be associated with senescence. In particular, the MSC cultures were incubated at 37°C for 30 min with each of the following drugs, separately: 100 nM Pertussis toxin (PTX, BMLG101-0050 Enzo Biochem, NY, USA) for the Gαi kinase, 1 μM YM-254890 (YM, 10–1590 Focus Biomolecules, PA, USA) to block Gαq/11, 50 μM D609 (sc201403, Santa Cruz Biotechology, CA, USA) to inhibit PLCβ, 10 μM BAPTA-AM (BPT) (15551 Cayman, MI, USA) and 10 mM 1,2,3,4-tetrahydrostaurosporine (STP, ab143861, Abcam, UK) for PKCα kinase inhibition, 5 nM PKCβi (Santa Cruz Biotech, TX, USA) for PKCβ inhibition, and 100 mM chlorpromazine (CPZ, sc-357313, Santa Cruz) to block endocytosis. Subsequently, we added 25 ng/ml IGF-II, and the samples were further incubated for 24 hr, and the senescence assays were performed. For each drug, we evaluated the inhibitory effect at the concentration we used (Figure 7—figure supplement 1).
+ Open protocol
+ Expand
6

Neutrophil Inhibitor Evaluation for Candida

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils were pre-treated with indicated inhibitors 30 min before addition of C. albicans. Inhibitors SkyI (for Syk), BAPTA-AM (a selective chelator of Ca2+), Ro 318220 (for total PKC), Rottlerin (for PKCδ), BB-CI-Amidine (for PAD1-4), GSK484 (for PAD4) were all purchased from Cayman. Ro 6976 (for PKCα+β1), LY 333531 (for PKCβ) were from Millipore.
+ Open protocol
+ Expand
7

Crustacean Neuromuscular Signaling Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tetrodotoxin (TTX), myristoylated PKI(14–22) and calcineurin autoinhibitory peptide (CiP) were purchased from Tocris Bioscience (Bristol, UK). BAPTA-AM, ryanodine and xestospongin C were from Cayman Chemical (Ann Arbor, MI). All other chemicals were purchased from Sigma-Aldrich (St. Louis, MI). DA was made fresh every 30min to minimize oxidation. PKI is an effective blocker of the PKA catalytic subunit in crustaceans [43 (link),46 (link),47 (link)]. CiP and FK506 block calcineurin activity in crustacean neurons at the indicated dosages [48 (link)–50 (link)]. In the spiny lobster, BAPTA, ryanodine and xestospongin C disrupt Ca2+ dynamics at the indicated dosages by chelating Ca2+, blocking ryanodine receptor function and inhibiting IP3 receptor function, respectively [51 (link)].
+ Open protocol
+ Expand
8

Comprehensive Reagent Acquisition Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals or reagents were obtained from Sigma-Aldrich unless specified otherwise. PJ34 was from Santa Cruz, DPQ from Calbiochem, Ac-DVED-CMK, GKT137831, BAPTA-AM and U0126 from Cayman Chemical, CTC and PF431396 from Tocris.
+ Open protocol
+ Expand
9

Investigating Calcium-Dependent Platelet Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the effect of calcium depletion on SMPA, GFP were treated with calcium chelators binding extracellular (EDTA) or intracellular (BAPTA-AM) calcium pools in platelets. Chosen concentrations of calcium chelators were shown to inhibit platelet membrane scrambling in previous studies. Specifically, non-recalcified GFP (20,000 platelets/uL) were treated with 1 mM EDTA (Sigma-Aldrich, St. Louis, MO) for 10 min31 (link),32 (link) and subjected to shear stress of 30 and 70 dynes/cm2 in the HSD or sonication. Then, activated GFP were recalcified with 2.5 mM CaCl2 and processed to detect annexin V binding as described below. Alternatively, non-recalcified GFP (100,000 platelets/uL) were loaded with 20 uM BAPTA-AM (Cayman Chemical, Ann Arbor, MI) for 30 min with minimal agitation on orbital shaker at room temperature33 (link). Residual solution-phase BAPTA was washed via second gel-filtration of BAPTA-treated GFP. Then, BAPTA-loaded GFP was diluted and recalcified to undergo shear exposure in the HSD or sonication as described above.
+ Open protocol
+ Expand
10

Neurochemical Modulation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Methamphetamine (Sigma-Aldrich; St. Louis, Missouri, USA), CdCl2 (Spectrum Chemical; Gardena, CA, USA), 1,2-Bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM; Cayman Chemical; Ann Arbor, MI, USA), cyclopiazonic acid (CPA; Cayman Chemical), 2-Aminoethoxydiphenylborane (2-APB; Tocris; Minneapolis, MN, USA), Thapsigargin (Tocris) were dissolved in stock solutions and then diluted into ACSF at specified concentrations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!